Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Login

    Generation Bio Co.

    NASDAQ: GBIO · Real-Time Price · USD
    0.39
    -0.05 (-10.55%)
    At close: Jun 09, 2025, 3:59 PM

    Generation Bio Statistics

    Share Statistics

    Generation Bio has 67.04M shares outstanding. The number of shares has increased by 0.72% in one year.

    Shares Outstanding

    n/a
    		 67.04M

    Shares Change (YoY)

    n/a
    		 0.72%

    Shares Change (QoQ)

    n/a
    		 0.32%

    Owned by Institutions (%)

    n/a
    		 80.69%

    Shares Floating

    n/a
    		 45.82M

    Failed to Deliver (FTD) Shares

    n/a
    		 4,477

    FTD / Avg. Volume

    n/a
    		 0.9%

    Short Selling Information

    The latest short interest is 1.89M, so 2.82% of the outstanding shares have been sold short.

    Short Interest

    n/a
    		 1.89M

    Short % of Shares Out

    n/a
    		 2.82%

    Short % of Float

    n/a
    		 4.11%

    Short Ratio (days to cover)

    n/a
    		 3.21

    Valuation Ratios

    The PE ratio is -0.54 and the forward PE ratio is -0.34. Generation Bio's PEG ratio is -0.53.

    PE Ratio

    n/a
    		 -0.54

    Forward PE

    n/a
    		 -0.34

    PS Ratio

    n/a
    		 3.55

    Forward PS

    n/a
    		 0.6

    PB Ratio

    n/a
    		 0.82

    P/FCF Ratio

    n/a
    		 -0.78

    PEG Ratio

    n/a
    		 -0.53
    Financial Ratio History

    Enterprise Valuation

    Currently the Enterprise Value (EV) is not available for Generation Bio.

    EV / Sales

    n/a
    		 n/a

    EV / EBITDA

    n/a
    		 n/a

    EV / EBIT

    n/a
    		 n/a

    EV / FCF

    n/a
    		 n/a

    Financial Position

    The company has a current ratio of 5.5, with a Debt / Equity ratio of 1.09.

    Current Ratio

    n/a
    		 5.5

    Quick Ratio

    n/a
    		 5.5

    Debt / Equity

    n/a
    		 1.09

    Debt / EBITDA

    n/a
    		 -1.26

    Debt / FCF

    n/a
    		 -1.03

    Interest Coverage

    n/a
    		 0

    Financial Efficiency

    Return on Equity is n/a and Return on Invested Capital is n/a.

    Return on Equity

    n/a
    		 n/a

    Return on Assets

    n/a
    		 n/a

    Return on Invested Capital

    n/a
    		 n/a

    Revenue Per Employee

    n/a
    		 $172,973.91

    Profits Per Employee

    n/a
    		 $-1,144,939.13

    Employee Count

    n/a
    		 115

    Asset Turnover

    n/a
    		 0.09

    Inventory Turnover

    n/a
    		 n/a

    Taxes

    Income Tax

    n/a
    		 n/a

    Effective Tax Rate

    n/a
    		 0%

    Stock Price Statistics

    The stock price has increased by -86.81% in the last 52 weeks. The beta is 2.66, so Generation Bio's price volatility has been higher than the market average.

    Beta

    n/a
    		 2.66

    52-Week Price Change

    n/a
    		 -86.81%

    50-Day Moving Average

    n/a
    		 0.39

    200-Day Moving Average

    n/a
    		 1.24

    Relative Strength Index (RSI)

    n/a
    		 59.13

    Average Volume (20 Days)

    n/a
    		 495,126

    Income Statement

    In the last 12 months, Generation Bio had revenue of 19.89M and earned -131.67M in profits. Earnings per share was -1.98.

    Revenue

    n/a
    		 19.89M

    Gross Profit

    n/a
    		 19.89M

    Operating Income

    n/a
    		 -142.39M

    Net Income

    n/a
    		 -131.67M

    EBITDA

    n/a
    		 -74.26M

    EBIT

    n/a
    		 -79.19M

    Earnings Per Share (EPS)

    n/a
    		 -1.98
    Full Income Statement

    Balance Sheet

    The company has 76.3M in cash and 93.56M in debt, giving a net cash position of -17.26M.

    Cash & Cash Equivalents

    n/a
    		 76.3M

    Total Debt

    n/a
    		 93.56M

    Net Cash

    n/a
    		 -17.26M

    Retained Earnings

    n/a
    		 -703.04M

    Total Assets

    n/a
    		 201.35M

    Working Capital

    n/a
    		 145.52M
    Full Balance Sheet

    Cash Flow

    In the last 12 months, operating cash flow was -88.56M and capital expenditures -2.4M, giving a free cash flow of -90.96M.

    Operating Cash Flow

    n/a
    		 -88.56M

    Capital Expenditures

    n/a
    		 -2.4M

    Free Cash Flow

    n/a
    		 -90.96M

    FCF Per Share

    n/a
    		 -1.37
    Full Cash Flow Statement

    Margins

    Gross margin is 100%, with operating and profit margins of -715.82% and -661.91%.

    Gross Margin

    n/a
    		 100%

    Operating Margin

    n/a
    		 -715.82%

    Pretax Margin

    n/a
    		 -661.91%

    Profit Margin

    n/a
    		 -661.91%

    EBITDA Margin

    n/a
    		 -373.33%

    EBIT Margin

    n/a
    		 -715.82%

    FCF Margin

    n/a
    		 -457.29%

    Dividends & Yields

    GBIO does not appear to pay any dividends at this time.

    Dividend Per Share

    n/a
    		 n/a

    Dividend Yield

    n/a
    		 n/a

    Dividend Growth (YoY)

    n/a
    		 n/a

    Payout Ratio

    n/a
    		 n/a

    Earnings Yield

    n/a
    		 n/a

    FCF Yield

    n/a
    		 n/a
    Dividend Details

    Analyst Forecast

    The average price target for GBIO is $8, which is 1760.5% higher than the current price. The consensus rating is "Buy".

    Price Target

    n/a
    		 $8

    Price Target Difference

    n/a
    		 1760.5%

    Analyst Consensus

    n/a
    		 Buy

    Analyst Count

    n/a
    		 4
    Stock Forecasts

    Fair Value

    There are several formulas that can be used to estimate the intrinsic value of a stock.

    Lynch Fair Value

    n/a
    		 n/a

    Lynch Upside

    n/a
    		 n/a

    Graham Number

    n/a
    		 n/a

    Graham Upside

    n/a
    		 n/a

    Scores

    Altman Z-Score

    n/a
    		 -5.1

    Piotroski F-Score

    n/a
    		 2

    Add to Watchlist